Evidence map›Paper›PMID 26893691›Full record

ArticleOncology letters2016

Cerebellar liponeurocytoma: A case report and review of the literature.

K E Wang, Ming Ni, Liang Wang, Guijun Jia, Zhen Wu, Liwei Zhang, Junting Zhang

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Cerebellar liponeurocytoma: illustrative case.Journal of neurosurgery. Case lessons · 2025
    Article
  2. Article
  3. Uncommon low-grade brain tumors.Neuro-oncology · 2019
    Review
  4. Article
  5. Article
  6. Multifocal cerebellar liponeurocytoma: How to deal with it?Journal of neurosciences in rural practice
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

K E WangSkull Base and Brainstem Tumor Division, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China; Beijing Institute for Brain Disorders, Brain Tumor Center, Capital Medical University, Beijing 100050, P.R. China; China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing 100050, P.R. China.
Ming NiSkull Base and Brainstem Tumor Division, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China; Beijing Institute for Brain Disorders, Brain Tumor Center, Capital Medical University, Beijing 100050, P.R. China; China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing 100050, P.R. China.
Liang WangSkull Base and Brainstem Tumor Division, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China; Beijing Institute for Brain Disorders, Brain Tumor Center, Capital Medical University, Beijing 100050, P.R. China; China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing 100050, P.R. China.
Guijun JiaSkull Base and Brainstem Tumor Division, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China; Beijing Institute for Brain Disorders, Brain Tumor Center, Capital Medical University, Beijing 100050, P.R. China; China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing 100050, P.R. China.
Zhen WuSkull Base and Brainstem Tumor Division, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China; Beijing Institute for Brain Disorders, Brain Tumor Center, Capital Medical University, Beijing 100050, P.R. China; China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing 100050, P.R. China.
Liwei ZhangSkull Base and Brainstem Tumor Division, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China; Beijing Institute for Brain Disorders, Brain Tumor Center, Capital Medical University, Beijing 100050, P.R. China; China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing 100050, P.R. China.
Junting ZhangSkull Base and Brainstem Tumor Division, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China; Beijing Institute for Brain Disorders, Brain Tumor Center, Capital Medical University, Beijing 100050, P.R. China; China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing 100050, P.R. China.
Beijing Tian Tan Hospital · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebellar liponeurocytoma is rare, and the clinical characteristics and treatment strategy remain unclear. In the present study, a case of cerebellar liponeurocytoma was retrospectively reported and a literature review was performed. A 45-year-old female presented due to occipital headaches, exhibiting a hoarse voice and a broad-based gait. Pre-operative magnetic resonance images revealed a lesion occupying the right hemisphere of the cerebellum and the inferior vermis, compressing the medulla oblongata from the right side, and extending through the foramen magnum to the C2 level. A total resection was performed, and pathological analysis of the lesion showed positivity for synaptophysin, S-100 and neuronal nuclear antigen, partial positivity for Olig-2, and negativity for glial fibrillary acidic protein and epithelial membrane antigen. In addition, the Ki-67 index was low (<5%). Thus, a diagnosis of cerebellar liponeurocytoma was determined. Total resection was successful and the patient was followed up closely. A review of the literature showed that cerebellar liponeurocytoma is mainly located in the cerebellum, with rare extra-cerebellar cases. Certain studies have suggested that the tumor may be located supratentorially and subtentorially, and should be renamed as solely liponeurocytoma. Total resection of the tumor contributes to an improved prognosis, while a subtotal resection and high Ki-67 index lead to recurrence. The tumor is similar to a tumor of low malignancy, with long-term recurrence. Radiation is recommended when there is residual tumor, recurrence or when the Ki-67 is high.

Indexed as

cerebellar liponeurocytomaliponeurocytomaradiationrecurrence

Identifiers

PMID26893691
PMCPMC4734111
OpenAlexW2187677756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.